PLUS.NASDAQEplus INC

Form 4: EPLUS Director Sells 560 Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


EPLUS Director John E. Callies sold 560 shares of common stock for approximately $90.03 per share on December 8, 2025, under a pre-arranged 10b5-1 plan.

Summary

  • John E. Callies, a Director of EPLUS INC, reported a sale of common stock.
  • The transaction involved the disposition of 560 shares of common stock.
  • The shares were sold on December 8, 2025, at a weighted average price of $90.0263 per share.
  • The total value of the transaction was approximately $50,414.73.
  • Following this transaction, Mr. Callies beneficially owns 21,428 shares of EPLUS INC common stock.
  • The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 5

Explanation: A Form 4 filing reports an insider transaction, which is a factual disclosure. The sale of shares by a director, particularly when executed pursuant to a pre-arranged Rule 10b5-1(c) plan, is generally considered a neutral event as it may reflect personal financial planning rather than a change in outlook on the company's prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders may note the director's sale, but the execution under a Rule 10b5-1(c) plan suggests it was pre-scheduled and not necessarily indicative of new information or a change in the director's view of the company.

Key Dates

DateDescription
12/08/2025Date of earliest transaction (sale of common stock)
12/10/2025Signature date of the reporting person

Keywords

EPLUS, PLUS, Form 4, Insider Trading, Director Stock Sale, John E. Callies, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.